Skip to content

Talphera, Inc. TLPH Price / book

Price / book at other companies

Baxter International logo
Baxter InternationalBAX
1.4×-1.0×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
49.5×+44.6×
Royalty Pharma logo
Royalty PharmaRPRX
2.1×+0.7×
PTH
Pelthos Therapeutics Inc.PTHS
XOMA Corporation logo
XOMA CorporationXOMA
+1.2×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.2×-16.1×

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Calculated from Talphera, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s price / book?
Talphera, Inc. (TLPH) reported price / book of 2× in Q1 2026.
How has Talphera, Inc.'s price / book changed year-over-year?
Talphera, Inc.'s price / book increased by 34.4% year-over-year, from 1.5× to 2×.
What is the long-term trend for Talphera, Inc.'s price / book?
Over 3 years (2022 to 2025), Talphera, Inc.'s price / book has grown at a 59.2% compound annual growth rate (CAGR), from 0.8× to 3.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.